首次获骨髓无白血病状态时血细胞恢复程度在成人急性髓系白血病患者中的预后意义
目的探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解（CR，ANC≥1．0×10^9／L和PLT≥100×10^9／L）、PLT未恢复（CRp）、ANC和PLT均未恢复（CRi）]对初治成人急性髓系白血病（AML）患者预后的影响。方法回顾2008年1月至2016年2月北京大学人民医院收治的获得骨髓无白血病状态后持续化疗AML（非急性早幼粒细胞白血病）连续病例，分析诊断时疾病特征、诱导化疗方案、首次诱导化疗反应以及骨髓无白血病状态时血细胞计数与预后的关系。结果352例患者，男179例（50．9％），中位年龄44（17～65）岁。按美国西南肿瘤组（SWOG）标准分组：低危87例（24．7％...
Saved in:
| Published in | 中华血液学杂志 Vol. 38; no. 3; pp. 185 - 191 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
100044,北京大学人民医院、北京大学血液病研究所
2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0253-2727 |
| DOI | 10.3760/cma.j.issn.0253-2727.2017.03.003 |
Cover
| Abstract | 目的探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解（CR，ANC≥1．0×10^9／L和PLT≥100×10^9／L）、PLT未恢复（CRp）、ANC和PLT均未恢复（CRi）]对初治成人急性髓系白血病（AML）患者预后的影响。方法回顾2008年1月至2016年2月北京大学人民医院收治的获得骨髓无白血病状态后持续化疗AML（非急性早幼粒细胞白血病）连续病例，分析诊断时疾病特征、诱导化疗方案、首次诱导化疗反应以及骨髓无白血病状态时血细胞计数与预后的关系。结果352例患者，男179例（50．9％），中位年龄44（17～65）岁。按美国西南肿瘤组（SWOG）标准分组：低危87例（24．7％），中危171例（48．6％），高危46例（13．1％），未知48例（13．6％）。单体核型16例（4．5％），FLT3-ITD突变阳性41例（11．6％）。首次获骨髓无白血病状态时血细胞恢复程度：CR299例（84．9％），CRp26例（7．4％），CRi27例（7．7％）。存活患者中位随访16（2～94）个月，30个月累积复发（CIR）、无病生存（DFS）和总生存（OS）率分别为47．5％、46．0％和58．6％。多因素分析显示，骨髓无白血病状态时血细胞恢复不良是影响患者CIR、DFS和OS的共同不利因素（HR=1．4，95％C11．0～1．9，P=0．037；HR=I．5，95％CI1．1-2．0，P=0．003；HR=1．5，95％CI1．1～2．0，P=0．017）。此外，SWOG分组危险度高和FLT3-ITD突变阳性是影响患者CIR、DFS和OS的共同不利因素；确诊时外周血原始细胞比例高是影响患者DFS的不利因素；年龄大和确诊时骨髓原始细胞比例高是影响患者OS的不利因素。结论持续化疗的成人AML患者，首次获骨髓无白血病状态时血细胞恢复程度是影响预后的独立因素。 |
|---|---|
| AbstractList | 目的 探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解(CR,ANC≥1.0×109/L和PLT≥100×109/L)、PLT未恢复(CRp)、ANC和PLT均未恢复(CRi)]对初治成人急性髓系白血病(AML)患者预后的影响.方法 回顾2008年1月至2016年2月北京大学人民医院收治的获得骨髓无白血病状态后持续化疗AML(非急性早幼粒细胞白血病)连续病例,分析诊断时疾病特征、诱导化疗方案、首次诱导化疗反应以及骨髓无白血病状态时血细胞计数与预后的关系.结果 352例患者,男179例(50.9%),中位年龄44(17~65)岁.按美国西南肿瘤组(SWOG)标准分组:低危87例(24.7%),中危171例(48.6%),高危46例(13.1%),未知48例(13.6%).单体核型16例(4.5%),FLT3-ITD突变阳性41例(11.6%).首次获骨髓无白血病状态时血细胞恢复程度:CR 299例(84.9%),CRp 26例(7.4%),CRi 27例(7.7%).存活患者中位随访16(2~94)个月,30个月累积复发(CIR)、无病生存(DFS)和总生存(OS)率分别为47.5%、46.0%和58.6%.多因素分析显示,骨髓无白血病状态时血细胞恢复不良是影响患者CIR、DFS和OS的共同不利因素(HR=1.4,95%CI 1.0~1.9,P=0.037;HR=1.5,95%CI 1.1~2.0,P=0.003;HR=1.5,95%CI 1.1~2.0,P=0.017).此外,SWOG分组危险度高和FLT3-ITD突变阳性是影响患者CIR、DFS和OS的共同不利因素;确诊时外周血原始细胞比例高是影响患者DFS的不利因素;年龄大和确诊时骨髓原始细胞比例高是影响患者OS的不利因素.结论 持续化疗的成人AML患者,首次获骨髓无白血病状态时血细胞恢复程度是影响预后的独立因素. 目的探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解（CR，ANC≥1．0×10^9／L和PLT≥100×10^9／L）、PLT未恢复（CRp）、ANC和PLT均未恢复（CRi）]对初治成人急性髓系白血病（AML）患者预后的影响。方法回顾2008年1月至2016年2月北京大学人民医院收治的获得骨髓无白血病状态后持续化疗AML（非急性早幼粒细胞白血病）连续病例，分析诊断时疾病特征、诱导化疗方案、首次诱导化疗反应以及骨髓无白血病状态时血细胞计数与预后的关系。结果352例患者，男179例（50．9％），中位年龄44（17～65）岁。按美国西南肿瘤组（SWOG）标准分组：低危87例（24．7％），中危171例（48．6％），高危46例（13．1％），未知48例（13．6％）。单体核型16例（4．5％），FLT3-ITD突变阳性41例（11．6％）。首次获骨髓无白血病状态时血细胞恢复程度：CR299例（84．9％），CRp26例（7．4％），CRi27例（7．7％）。存活患者中位随访16（2～94）个月，30个月累积复发（CIR）、无病生存（DFS）和总生存（OS）率分别为47．5％、46．0％和58．6％。多因素分析显示，骨髓无白血病状态时血细胞恢复不良是影响患者CIR、DFS和OS的共同不利因素（HR=1．4，95％C11．0～1．9，P=0．037；HR=I．5，95％CI1．1-2．0，P=0．003；HR=1．5，95％CI1．1～2．0，P=0．017）。此外，SWOG分组危险度高和FLT3-ITD突变阳性是影响患者CIR、DFS和OS的共同不利因素；确诊时外周血原始细胞比例高是影响患者DFS的不利因素；年龄大和确诊时骨髓原始细胞比例高是影响患者OS的不利因素。结论持续化疗的成人AML患者，首次获骨髓无白血病状态时血细胞恢复程度是影响预后的独立因素。 |
| Abstract_FL | Objective To explore prognostic significance of blood count at the time of achieving first morphologic leukemia-free state[complete remission(CR, ANC ≥1 × 109/L and PLT≥100 × 109/L), CR with incomplete PLT recovery(CRp)and CR with incomplete ANC and PLT recovery(CRi)]in adult patients with de novo acute myeloid leukemia(AML). Methods From January 2008 to February 2016, data of consecutive newly-diagnosed AML(non-APL)adults who received continuous chemotherapy in our hospital were analyzed retrospectively. Results 352 patients were included in the study. 179(50.9%) were male. Median age was 44(17-65)years. Using the SWOG cytogenetic classification, 87(24.7%), 171(48.6%), 46(13.1%)and 48(13.6%)patients belonged to favorable, intermediate, unfavorable and unknown categories, respectively. 16(4.5%)had monosomal karyotype and 41(11.6%)had FLT3-ITD mutation positive. Best response achieved at the time of achieving first morphologic leukemia-free state was CR in 299(84.9%)patients, CRp in 26(7.4%)and CRi in 27(8.1%). With a median follow-up period of 16(2-94)months in survivors, the probabilities of cumulative incident of relapse(CIR)rate, disease free survival (DFS) and overall survival (OS) at 30 months were 47.5%, 46.0% and 58.6%, respectively. Multivariate analyses showed that non-CR(CRp or CRi), was associated with high relapse rate, shorter DFS and OS. In addition, intermediate or high risk of SWOG cytogenetic classification and FLT3-ITD positive were common unfavorable factors affecting CIR, DFS and OS. Peripheral blast≥60%at diagnosis was adverse factors affecting DFS. Age ≥48 years and bone marrow blasts ≥67% were associated with shorter OS. Conclusion Blood count at the time of achieving morphologic leukemia-free state was one of the key markers associated with treatment outcomes in adults with AML. |
| Author | 任欣 赵婷 王婧 主鸿鹄 江浩 贾晋松 杨申淼 江滨 王德炳 黄晓军 江倩 |
| AuthorAffiliation | 北京大学人民医院、北京大学血液病研究所,100044 |
| AuthorAffiliation_xml | – name: 100044,北京大学人民医院、北京大学血液病研究所 |
| Author_FL | Jiang Hao Jiang Bin Jiang Qian Wang Debing Yang Shenmiao Zhao Ting Zhu Honghu Jia Jinsong Huang Xiaojun Ren Xin Wang Jing |
| Author_FL_xml | – sequence: 1 fullname: Ren Xin – sequence: 2 fullname: Zhao Ting – sequence: 3 fullname: Wang Jing – sequence: 4 fullname: Zhu Honghu – sequence: 5 fullname: Jiang Hao – sequence: 6 fullname: Jia Jinsong – sequence: 7 fullname: Yang Shenmiao – sequence: 8 fullname: Jiang Bin – sequence: 9 fullname: Wang Debing – sequence: 10 fullname: Huang Xiaojun – sequence: 11 fullname: Jiang Qian |
| Author_xml | – sequence: 1 fullname: 任欣 赵婷 王婧 主鸿鹄 江浩 贾晋松 杨申淼 江滨 王德炳 黄晓军 江倩 |
| BookMark | eNo9kE1LAlEUhu_CILX-RIto43Rm7jh3XIb0BUIb93LvNOMHOZZDpK3G0uiDTAiSIiKtTPpYBVZK_8a5M_6LRoxWh3PO874vvCEUMAumjtCCCAImCixqeSrkhKxlmQJIURyRiEQECUQiABYAcAAF_-_TKGRZOQDZ_8tBVBh1rvhby6t_jl66o9dL3rx3r3-8lu02a-5pj9sV3uyN18GRd3jHK23n8dztnjn9jnPb5ceNYb_P7SduP_ta92Pwr-UHD55dG369uzfVUbvqNOq8ejH8PplBUwbdsvTZvxlGyZXlZHwtkthYXY8vJSJaVMWRGGWgaCyKVVUF0HWmbcqayCCmYFDAYIxhXWISNkSZgkGoalBsyEyiOtVAxRiH0fzEdo-aBjXTqVxht2j6gan9TKlcGncD2G_GB-cmoJYpmOmdrI9uF7N5WiynFCJGFSBExb-7RZL9 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3760/cma.j.issn.0253-2727.2017.03.003 |
| DatabaseName | 中文期刊服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Prognostic significance of blood count at the time of achieving morphologic leukemia-free state in adults with acute myeloid leukemia |
| DocumentTitle_FL | Prognostic significance of blood count at the time of achieving morphologic leukemia-free state in adults with acute myeloid leukemia |
| EndPage | 191 |
| ExternalDocumentID | zhxyx201703003 671560778 |
| GroupedDBID | --- -05 2B. 2C~ 2RA 92F 92I 92L ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 F5P OK1 RPM TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI PSX |
| ID | FETCH-LOGICAL-c583-9ab06cb5388800eebcd4c1b0963060fbbb3e2b23f14a0f7a8fa3f4b2aeac08333 |
| ISSN | 0253-2727 |
| IngestDate | Thu May 29 04:00:17 EDT 2025 Wed Feb 14 10:01:39 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Prognosis 白血病,髓系,急性 预后 Leukemia,myeloid,acute 诱导缓解 Blood cell count 血细胞计数 Remission induction |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c583-9ab06cb5388800eebcd4c1b0963060fbbb3e2b23f14a0f7a8fa3f4b2aeac08333 |
| Notes | Ren ）（in, Zhao Ting, Wang Jing, Zhu Honghu, Jiang Hao, Jia Jinsong, Yang Shenmiao, Jiang Bin, Wang Debing, Huang Xiaojun, Jiang Qian. （Peking University People＇s Hospital, Peking University Institute of Hematology, Beijing 100044, China） Objective To explore prognostic significance of blood count at the time of achieving first morphologic leukemiafree state [ complete remission （CR, ANC ≥ 1 × 10^9/L and PLT≥ 100 × 10^9/L）, CR with incomplete PLT recovery （CRp） and CR with incomplete ANC and PLT recovery （CRi） ] in adult patients with de novo acute myeloid leukemia （AML）. Methods From January 2008 to February 2016, data of consecutive newly-diagnosed AML （non-APL） adults who received continuous chemotherapy in our hospital were analyzed retrospectively. Results 352 patients were included in the study. 179 （50.9%） were male. Median age was 44 （17-65） years. Using the SWOG cytogenetic classification, 87 （24.7%）, 171 （48.6%）, 46 （13.1%） and 48 （13.6%） patients belonged to favorable, intermediate, unfavorable and u |
| PageCount | 7 |
| ParticipantIDs | wanfang_journals_zhxyx201703003 chongqing_primary_671560778 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 中华血液学杂志 |
| PublicationTitleAlternate | Chinese Journal of Hematology |
| PublicationTitle_FL | Chinese Journal of Hematology |
| PublicationYear | 2017 |
| Publisher | 100044,北京大学人民医院、北京大学血液病研究所 |
| Publisher_xml | – name: 100044,北京大学人民医院、北京大学血液病研究所 |
| SSID | ssj0042014 ssib051368330 ssib017477332 ssib001103535 ssib058574913 |
| Score | 2.1187189 |
| Snippet | 目的探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解（CR，ANC≥1．0×10^9／L和PLT≥100×10^9／L）、PLT未恢复（CRp）、ANC和PLT均未恢复（CRi）]对初治成人急性髓... 目的 探讨首次获骨髓无白血病状态时血细胞恢复程度[包括完全缓解(CR,ANC≥1.0×109/L和PLT≥100×109/L)、PLT未恢复(CRp)、ANC和PLT均未恢复(CRi)]对初治成人急性髓系白血... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 185 |
| SubjectTerms | 白血病，髓系，急性 血细胞计数 诱导缓解 预后 |
| Title | 首次获骨髓无白血病状态时血细胞恢复程度在成人急性髓系白血病患者中的预后意义 |
| URI | http://lib.cqvip.com/qk/93752X/201703/671560778.html https://d.wanfangdata.com.cn/periodical/zhxyx201703003 |
| Volume | 38 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAQN databaseName: PubMed Central issn: 0253-2727 databaseCode: RPM dateStart: 20150101 customDbUrl: isFulltext: true dateEnd: 99991231 titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ omitProxy: true ssIdentifier: ssj0042014 providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFA61gvgiioq2XvrggLBsTTJJZuYx02Ypgj5V6NuSye62CG69tFD7tNVWvGAtCBZFxFatxcuTULXFf9PNtv_Cc2ay21ikXmAJZ8-eyzfnZDNnhpmJZZ1TFSEYrVSKNKDVoseUXVS04hSduOZwO4jtaozzkJcuB0NXvIsj_khXd09u1dLkhOpPpn-7r-R_sgo8yCvukv2HzHaMAgNoyC9cIcNw_asck0iQMCAiIFFAwgESOiTihEdEMv1TSEKuCUkERRnBSGiTiBEhiBxEYVDhhsMI95HgIZHaIPC5k2khJycsJeGawykRkRZ2SOiSyCchFKeDKAOuuUSODBEkEGJA4wFhTgTY8fAn-Bhfod8mWA4z-KLobi_MoOWSkGo8tuaAZRDTMERIuKcNuprw0TU3mAFqSQsLYt4w1C7TcxZ8bA7Kd_wGGA1pGjuomwYhGkQM2NgSEZ2uXZuRGr7JDy2gHenjB9WhRayggx5lwQJWiCztHxWFJkqaAJheQQNwiChpAjWMUdDQrYIwcZlhklEhozDwEAwPw4l6ENeBXaYkCP0KRpo7iWHbJGIXOvNe5gbz4-ONIGTelK-TKPLzSWbjbNbhuD4tusyc1dDuHSnPPQVorqtzzKuWsqrJMe9c290h45Ir-Bcl1-L-q9pJf8cJLqtk5oBhulOMdJaIBgz3-DPG91n7XZxr2zUTB2Ur9XdKfRhYM5Y7is93aMD1wmlTlXngTR8l13Z_wDqf4bvwJ3R47MrYeH30BhSTem9fvRbXR3Nl6PBh61A2fuwLzcPgiNU1PXbUGt9eeZZ-Wtqa_7r9YXX749N08XXr-Y-tpUZrca71cC1tzKSLa_h1497W3VfpzHLz7ePW6qPm-krz5Wp6f2FzfT1tvEsb70G39WWjo5veebPVmNv89rn1YnZ7eba5MJ_OPtn8_uCYNVyKhgeGitmbVIqJz2lRxMoOEgW1DfTWdrWqkoqXOMqGztcO7JpSilZd5dKa48V2jcW8FtOap9wYqjIYolF63Oquj9erJ6w-UUkUU0rASAaEHcUd6PJjkfgMFBLlnbR6O7EqXzcH5pQ7uTxpnc2iV84eo7fK02NTt6cw2lBu2LRnT_1e6yBKminQU1b3xM3J6mkYFEyoM_ru-AkOENV1 |
| linkProvider | National Library of Medicine |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%A6%96%E6%AC%A1%E8%8E%B7%E9%AA%A8%E9%AB%93%E6%97%A0%E7%99%BD%E8%A1%80%E7%97%85%E7%8A%B6%E6%80%81%E6%97%B6%E8%A1%80%E7%BB%86%E8%83%9E%E6%81%A2%E5%A4%8D%E7%A8%8B%E5%BA%A6%E5%9C%A8%E6%88%90%E4%BA%BA%E6%80%A5%E6%80%A7%E9%AB%93%E7%B3%BB%E7%99%BD%E8%A1%80%E7%97%85%E6%82%A3%E8%80%85%E4%B8%AD%E7%9A%84%E9%A2%84%E5%90%8E%E6%84%8F%E4%B9%89&rft.jtitle=%E4%B8%AD%E5%8D%8E%E8%A1%80%E6%B6%B2%E5%AD%A6%E6%9D%82%E5%BF%97&rft.au=%E4%BB%BB%E6%AC%A3+%E8%B5%B5%E5%A9%B7+%E7%8E%8B%E5%A9%A7+%E4%B8%BB%E9%B8%BF%E9%B9%84+%E6%B1%9F%E6%B5%A9+%E8%B4%BE%E6%99%8B%E6%9D%BE+%E6%9D%A8%E7%94%B3%E6%B7%BC+%E6%B1%9F%E6%BB%A8+%E7%8E%8B%E5%BE%B7%E7%82%B3+%E9%BB%84%E6%99%93%E5%86%9B+%E6%B1%9F%E5%80%A9&rft.date=2017&rft.issn=0253-2727&rft.volume=38&rft.issue=3&rft.spage=185&rft.epage=191&rft_id=info:doi/10.3760%2Fcma.j.issn.0253-2727.2017.03.003&rft.externalDocID=671560778 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93752X%2F93752X.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhxyx%2Fzhxyx.jpg |